EUVIMEDEUVIMED entdecken
Open Access

Applying whole genome sequencing to predict phenotypic drug resistance in Mycobacterium tuberculosis : leveraging 20 years of nationwide data from Denmark

Mads Lindholm Kurtzhals iD, Anders Norman iD, Erik Svensson iD, Troels Lillebaek iD, Dorte Bek Folkvardsen iD

Antimicrobial Agents and Chemotherapy · 2024

DOI: 10.1128/aac.00430-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2024. Verfasst von Mads Lindholm Kurtzhals und 4 weiteren Autor:innen. Beteiligte Einrichtung: International Reference Laboratory of Mycobacteriology, Statens Serum Institut, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Whole Genome Sequencing, Antitubercular Agents, Microbial Sensitivity Tests. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 11 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Infection with Mycobacterium tuberculosis remains one of the biggest causes of death from a single microorganism worldwide, and the continuous emergence of drug resistance aggravates our ability to cure the disease. New improved resistance detection methods are needed to provide adequate treatment, such as whole genome sequencing (WGS), which has been used increasingly to identify resistance-conferring mutations over the last decade. The steadily increasing knowledge of resistance-conferring mutations increases our ability to predict resistance based on genomic data alone. This study evaluates the performance of WGS to predict M. tuberculosis complex resistance. It compares WGS predictions with the phenotypic (culture-based) drug susceptibility results based on 20 years of nationwide Danish data. Analyzing 6,230 WGS-sequenced samples, the sensitivities for isoniazid, rifampicin, ethambutol, and pyrazinamide were 82.5% [78.0%–86.5%, 95% confidence interval (CI)], 97.3% (90.6%–99.7%, 95% CI), 58.0% (43.2%–71.8%, 95% CI), and 60.5% (49.0%–71.2%, 95% CI), respectively, and specificities were 99.8% (99.7%–99.9%, 95% CI), 99.8% (99.7%–99.9%, 95% CI), 99.4% (99.2%–99.6%, 95% CI), and 99.9% (99.7%–99.9%, 95% CI), respectively. A broader range of both sensitivities and specificities was observed for second-line drugs. The results conform with previously reported values and indicate that WGS is reliable for routine resistance detection in resource-rich tuberculosis low-incidence and low-resistance settings such as Denmark.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisWhole Genome SequencingAntitubercular AgentsMicrobial Sensitivity TestsDenmarkHumansTuberculosis, Multidrug-ResistantIsoniazidEthambutolRifampinPyrazinamideMutationDrug Resistance, Multiple, BacterialGenome, Bacterial

Stichwörter der Autor:innen

resistancetuberculosiswhole genome sequencing

Substanzen

Antitubercular AgentsIsoniazidEthambutolRifampinPyrazinamide

Autor:innen und Institutionen

  • International Reference Laboratory of Mycobacteriology, Statens Serum Institut, Copenhagen, Denmark.
  • Global Health Section, Department of Public Health, University of Copenhagen, Copenhagen, Denmark.

ORCID-Profile: Mads Lindholm Kurtzhals, Anders Norman, Erik Svensson, Troels Lillebaek, Dorte Bek Folkvardsen

Zitieren

APA

Kurtzhals, M. L., Norman, A., Svensson, E., Lillebaek, T., & Folkvardsen, D. B. (2024). Applying whole genome sequencing to predict phenotypic drug resistance in Mycobacterium tuberculosis : leveraging 20 years of nationwide data from Denmark. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00430-24

Vancouver

Kurtzhals ML, Norman A, Svensson E, Lillebaek T, Folkvardsen DB. Applying whole genome sequencing to predict phenotypic drug resistance in Mycobacterium tuberculosis : leveraging 20 years of nationwide data from Denmark. Antimicrobial Agents and Chemotherapy. 2024. doi:10.1128/aac.00430-24

BibTeX
@article{Kurtzhals2024,
  author = {Kurtzhals, Mads Lindholm and Norman, Anders and Svensson, Erik and Lillebaek, Troels and Folkvardsen, Dorte Bek},
  title = {Applying whole genome sequencing to predict phenotypic drug resistance in Mycobacterium tuberculosis : leveraging 20 years of nationwide data from Denmark},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2024},
  doi = {10.1128/aac.00430-24}
}
Kostenlos starten →